|
1
|
Lord RS, Bongiovanni B and Bralley JA:
Estrogen metabolism and the diet-cancer connection: rationale for
assessing the ratio of urinary hydroxylated estrogen metabolites.
Altern Med Rev. 7:112–129. 2002.PubMed/NCBI
|
|
2
|
He YY, Cai B, Yang YX, Liu XL and Wan XP:
Estrogenic G protein-coupled receptor 30 signaling is involved in
regulation of endometrial carcinoma by promoting proliferation,
invasion potential, and interleukin-6 secretion via the MEK/ERK
mitogen-activated protein kinase pathway. Cancer Sci.
100:1051–1061. 2009. View Article : Google Scholar
|
|
3
|
Vijayanathan V, Venkiteswaran S, Nair SK,
Verma A, Thomas TJ, Zhu BT and Thomas T: Physiologic levels of
2-methoxyestradiol interfere with nongenomic signaling of
17β-estradiol in human breast cancer cells. Clin Cancer Res.
12:2038–2048. 2006.PubMed/NCBI
|
|
4
|
Lewis-Wambi JS and Jordan VC: Estrogen
regulation of apoptosis: how can one hormone stimulate and inhibit?
Breast Cancer Res. 11:2062009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ciocca DR and Fanelli MA: Estrogen
receptors and cell proliferation in breast cancer. Trends
Endocrinol Metab. 8:313–321. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song RX and Santen RJ: Membrane initiated
estrogen signaling in breast cancer. Biol Reprod. 75:9–16. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hua K, Feng W, Cao Q, Zhou X, Lu X and
Feng Y: Estrogen and progestin regulate metastasis through the
PI3K/AKT pathway in human ovarian cancer. Int J Oncol. 33:959–967.
2008.PubMed/NCBI
|
|
8
|
Pietras RJ: Interaction between estrogen
and growth factor receptors in human breast cancers and
tumor-associated vasculature. Breast J. 9:361–373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Losordo DW and Isner JM: Estrogen and
angiogenesis: A review. Arterioscler Thromb Vasc Biol. 21:6–12.
2001. View Article : Google Scholar
|
|
10
|
Risau W: Mechanism of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aghi M and Chiocca EA: Contribution of
bone marrow-derived cells to blood vessels in ischemic tissues and
tumors. Mol Ther. 6:994–1005. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Young PP, Vaughan DE and Hatzopoulos AK:
Biological properties of endothelial progenitor cells (EPCs) and
their potential for cell therapy. Prog Cardiovasc Dis. 49:421–429.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masuda H and Asahara T: Post-natal
endothelial progenitor cells for neovascularization in tissue
regeneration. Cardiovasc Res. 58:390–398. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rehman J, Li J, Orschell CM and March KL:
Peripheral blood ‘endothelial progenitor cells’ are derived from
monocytes/macrophages and secrete angiogenic growth factors.
Circulation. 107:1164–1169. 2003.
|
|
15
|
Asahara T, Takahashi T, Masuda H, Kalka C,
Chen D, Iwaguro H, Inai Y, Silver M and Isner JM: VEGF contributes
to postnatal neovascularization by mobilizing bone marrow-derived
endothelial progenitor cells. EMBO J. 18:3964–3972. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suriano R, Chaudhuri D, Johnson RS,
Lambers E, Ashok BT, Kishore R and Tiwari RK: 17β-Estradiol
mobilizes bone marrow-derived endothelial progenitor cells to
tumors. Cancer Res. 68:6038–6042. 2008.
|
|
17
|
Ramsden JD: Angiogenesis in the thyroid
gland. J Endocrinol. 166:475–480. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics. CA Cancer J Clin. 59:225–249. 2009.
|
|
19
|
Cook MB, Dawsey SM, Freedman ND, Inskip
PD, Wichner SM, Quraishi SM, Devesa SS and McGlynn KA: Sex
disparities in cancer incidence by period and age. Cancer Epidemiol
Biomarkers Prev. 18:1174–1182. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Levi F, Franceschi S, Gulie C, Negri E and
Vecchia CL: Female thyroid cancer: the role of reproductive and
hormonal factors in Switzerland. Oncology. 50:309–315. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Furlanetto TW, Nguyen LQ and Jameson JL:
Estradiol increases proliferation and down-regulates the
sodium/iodide symporter gene in FRTL-5 cells. Endocrinology.
140:5705–5711. 1999.PubMed/NCBI
|
|
22
|
Manole D, Schildknecht B, Gosnell B, Adams
E and Derwahl M: Estrogen promotes growth of human thyroid tumor
cells by different molecular mechanisms. J Clin Endocrinol Metab.
86:1072–1077. 2001.PubMed/NCBI
|
|
23
|
Rajoria S, Suriano R, Shanmugam A, Wilson
YL, Schantz SP, Geliebter J and Tiwari RK: Metastatic phenotype is
regulated by estrogen in thyroid cells. Thyroid. 20:33–41. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schweppe RE, Klopper JP, Korch C,
Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow L, Copland JA,
Smallridge RC and Haugen BR: Deoxyribonucleic acid profiling
analysis of 40 human thyroid cancer cell lines reveals
cross-contamination resulting in cell line redundancy and
misidentification. J Clin Endocrinol Metab. 93:4331–4341. 2008.
View Article : Google Scholar
|
|
25
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Patore C, Silver M, Marianne K, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculogenesis in physiological and pathological
neovascularization. Circ Res. 85:221–228. 1999. View Article : Google Scholar
|
|
26
|
Gehling UM, Ergun S, Schumacher U, Wagener
C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N,
Kluge K, Schafer B, Hossfeld DK and Fiedler W: In vitro
differentiation of endothelial cells from AC133-positive progenitor
cells. Blood. 95:3106–3112. 2000.
|
|
27
|
Khakhoo AY and Finkel T: Endothelial
progenitor cell. Ann Rev Med. 56:79–101. 2005. View Article : Google Scholar
|
|
28
|
Dong F and Ha X-Q: Effect of endothelial
progenitor cells in neovascularization and their application in
tumor therapy. China Med J. 123:2454–2460. 2010.PubMed/NCBI
|
|
29
|
Wu LC and Zhang WD: Clinical trials of
antiangiogenesis therapy on gastric cancer. Gastroenterol Res.
1:14–19. 2008.
|
|
30
|
Kerbel RS: Antiangiogenic therapy: A
universal chemosensitization strategy for cancer? Science.
312:1171–1175. 2006. View Article : Google Scholar : PubMed/NCBI
|
